Colonic absorption of insulin-like growth factor I in vitro

Pharm Res. 1994 Feb;11(2):226-30. doi: 10.1023/a:1018999106684.

Abstract

Colonic absorption of recombinant human insulin-like growth factor I (rhIGF-I) was measured in vitro using both rat and minipig colon. The permeability coefficients were 8.03 +/- 1.03 and 4.75 +/- 0.43 x 10(-8) cm sec-1 in the rat and minipig, respectively. The steady-state flux in rat colon was linearly related to the donor concentration over the range 1 to 10 mg/mL. rhIGF-I was metabolically stable in contact with both mucosal and serosal surfaces of washed colon for 5 hr. The amount of IGF-I permeating through the tissue was quantitated by radioimmunoassay and the identity and integrity of the permeating species were confirmed by reverse-phase HPLC, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and Western blotting. In all cases the permeant was identical to authentic rhIGF-I. The integrity of the colonic tissue in vitro was demonstrated by the maintenance of electrophysiological parameters, a secretory response to serosal theophylline, and the ability of sodium azide, a metabolic inhibitor, to abolish the barrier properties and cause a large increase in flux.

MeSH terms

  • Animals
  • Azides / pharmacology
  • Blotting, Western
  • Chromatography, High Pressure Liquid
  • Colon / drug effects
  • Colon / metabolism*
  • Drug Delivery Systems
  • Electrophoresis, Polyacrylamide Gel
  • Electrophysiology
  • Humans
  • In Vitro Techniques
  • Insulin-Like Growth Factor I / administration & dosage
  • Insulin-Like Growth Factor I / pharmacokinetics*
  • Intestinal Absorption*
  • Male
  • Radioimmunoassay
  • Rats
  • Rats, Sprague-Dawley
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / pharmacokinetics
  • Sodium Azide
  • Swine
  • Swine, Miniature
  • Theophylline / pharmacology

Substances

  • Azides
  • Recombinant Proteins
  • Insulin-Like Growth Factor I
  • Sodium Azide
  • Theophylline